Pharmacological Inhibition of the Skeletal IKKβ Reduces Breast Cancer-Induced Osteolysis.

about

Pharmacological Inhibition of the Skeletal IKKβ Reduces Breast Cancer-Induced Osteolysis.

Item

http://www.wikidata.org/entity/Q49891124

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Pharmacological Inhibition of the Skeletal IKKβ Reduces Breast Cancer-Induced Osteolysis.

@en

Pharmacological Inhibition of the Skeletal IKKβ Reduces Breast Cancer-Induced Osteolysis.

@nl

type

Item

label

Pharmacological Inhibition of the Skeletal IKKβ Reduces Breast Cancer-Induced Osteolysis.

@en

Pharmacological Inhibition of the Skeletal IKKβ Reduces Breast Cancer-Induced Osteolysis.

@nl

prefLabel

Pharmacological Inhibition of the Skeletal IKKβ Reduces Breast Cancer-Induced Osteolysis.

@en

Pharmacological Inhibition of the Skeletal IKKβ Reduces Breast Cancer-Induced Osteolysis.

@nl

P1476

Pharmacological Inhibition of the Skeletal IKKβ Reduces Breast Cancer-Induced Osteolysis.

@en

P2093

Patrick Mollat

http://www.w3.org/2001/XMLSchema#string

Silvia Marino

http://www.w3.org/2001/XMLSchema#string

P2860

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice

Metastatic bone disease: clinical features, pathophysiology and treatment strategies

The IkappaB kinase - a bridge between inflammation and cancer

Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin

TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling

Osteoclast differentiation is impaired in the absence of inhibitor of kappa B kinase alpha

Metastasis to bone: causes, consequences and therapeutic opportunities

Molecular interactions between breast cancer cells and the bone microenvironment drive skeletal metastases.

American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel.

P2888

s00223-018-0406-4

P31

scholarly article

P356

10.1007/S00223-018-0406-4

http://www.w3.org/2001/XMLSchema#string

P407

English

P50

Aymen I. Idris

Ryan T. Bishop

P577

2018-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1101084017

http://www.w3.org/2001/XMLSchema#string

P698

29455416

http://www.w3.org/2001/XMLSchema#string

P932

6061461

http://www.w3.org/2001/XMLSchema#string